title: Role of lenalidomide in the management of myelodysplastic syndromes with del(5q) associated with pure red cell aplasia (PRCA).
authors.affiliation: Hematology, AOU Federico II, Naples, Italy, claudiocerc@hotmail.com.
authors.forename: Claudio
authors.initials: C
authors.lastname: Cerchione
authors.forename: Lucio
authors.initials: L
authors.lastname: Catalano
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Cerciello
authors.forename: Simona
authors.initials: S
authors.lastname: Avilia
authors.forename: Marco
authors.initials: M
authors.lastname: Picardi
authors.forename: Antonio Maria
authors.initials: AM
authors.lastname: Risitano
authors.forename: Ida
authors.initials: I
authors.lastname: Pisano
authors.forename: Fiorella
authors.initials: F
authors.lastname: Alfinito
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Pane
mesh_terms: D000328:Adult; D000368:Aged; D002872:Chromosome Deletion; D002895:Chromosomes, Human, Pair 5 / Q000235:genetics; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D012010:Red-Cell Aplasia, Pure / Q000150:complications / Q000188:drug therapy* / Q000235:genetics*; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D013792:Thalidomide; D000077269:Lenalidomide